BUZZ-India's Divi's Labs slides on risk of generic versions of top drug ** Shares of Divi's Laboratories DIVI.NS fall 4.2% to 4,656 rupees, the most on the Nifty 50 .NSEI ** Novartis NOVN.S loses initial bid to block generic versions of its top-selling heart drug Entresto, for which Divi's supplies pharma ingredients, or APIs ** Entresto is among l

Swiss stocks - Factors to watch on August 13 ZURICH/GDANSK, Aug 13 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Tuesday: COMPANY STATEMENTS SCHINDLER HOLDING AG SCHP.S Wins Avenues - Riyadh project in Saudi Arabia. TECAN GROUP TECN.S Reports HY adjusted EBITDA of 67.9 million Swiss francs. NOVARTIS NOVN.S Lost initial bid to block generic of best-selling heart drug.

UPDATE 1-Novartis loses initial bid to block generic of best-selling heart drug Adds response from Novartis in paragraph 4 By Blake Brittain Aug 12 (Reuters) - Novartis NOVN.S failed to convince a federal court to block generic drugmaker MSN Pharmaceuticals from launching its own version of Novartis' blockbuster heart-failure drug Entresto, according to a court decision issued on Monday.

Novartis loses initial bid to block generic of best-selling heart drug By Blake Brittain Aug 12 (Reuters) - Novartis NOVN.S failed to convince a Delaware federal court to block generic drugmaker MSN Pharmaceuticals from launching its own version of Novartis' blockbuster heart-failure drug Entresto, according to a court decision issued on Monday. U.S.

Swiss stocks - Factors to watch on August 8 ZURICH/GDANSK, Aug 8(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: NOVARTIS NOVN.S Novartis Says Receives FDA Accelerated Approval For Fabhalta. ZURICH INSURANCE GROUP AG ZURN.S Zurich Insurance posted a better than expected rise in first-half business operating profit to $4.0 billion due to an ongoing robust performance in P&C, a record BOP in the Life business and excellent growth at Farmers, it said on Thursd